Shares of Humana Inc. (NYSE:HUM) were downgraded by Tobam

VaselineOctober 10, 2024

0 3 minutes read

Tobam reduced its stake in Humana Inc. (NYSE:HUM – Free Report) by 19.4% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 36,383 shares of the insurance provider’s stock after selling 8,782 shares during the period. Humana makes up about 2.1% of Tobam’s holdings, making the stock its 11th biggest position. Tobam’s holdings in Humana were worth $11,524,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the company. Point72 Hong Kong Ltd acquired a new position in Humana in the 4th quarter valued at about $23,782,000. Kingfisher Capital LLC purchased a new position in Humana in the 4th quarter valued at approximately $2,250,000. Cobalt Capital Management Inc. purchased a new position in Humana during the fourth quarter valued at about $2,289,000. Chilton Investment Co. Inc. purchased a new position in Humana during the fourth quarter valued at about $706,000. Finally, Caden Capital Partners LP acquired a new position in Humana in the fourth quarter valued at approximately $12,232,000. Institutional investors own 92.38% of the company’s shares.

Changes in Analyst Ratings

Several equities analysts recently commented on HUM shares. Leerink Partners cut shares of Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Truist Financial boosted their target price on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a report on Monday, July 15th. Cantor Fitzgerald restated a “neutral” rating and set a $395.00 target price on shares of Humana in a report on Tuesday, October 1st. JPMorgan Chase & Co. upped their target price on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Finally, Morgan Stanley assumed coverage on shares of Humana in a report on Monday, June 24th. They set an “equal weight” rating and a $374.00 price target on the stock. One investment analyst has rated the stock with a sell rating, eighteen have issued a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $324.86, according to MarketBeat.

Want more great investment ideas?

Get the latest stock analysis on Humana

Humana stocks by 1.7%

Humana stock traded up $4.25 during mid-day trading on Thursday, reaching $249.70. The company’s stock had a trading volume of 1,128,122 shares, compared to its average volume of 1,793,047. The company has a market cap of $30.09 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 2.44 and a beta of 0.50. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $530.54. The company’s 50-day simple moving average is $329.03, and its 200-day simple moving average is $341.40. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66, and a current ratio of 1.66.

Humana (NYSE:HUM – Get Your Free Report ) last issued its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. Humana’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the prior year, the business earned $8.94 EPS. As a group, research analysts anticipate that Humana Inc. will post 16.01 earnings per share for the current year.

Humana announces dividends

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Monday, September 30. This represents an annualized dividend of $3.54 and a dividend yield of 1.42%. Humana’s dividend payout ratio is currently 22.04%.

Humana profile

(Free report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. Has a contract with the Centers for Medicare and Medicaid Services to administer the newly eligible limited income transition program for prescription drugs; and contracts with various states to provide Medicaid benefits, dual eligibles, and long-term care services.